Carlos Fernández-Hernando (EN)
Professor Anthony N. Brady, Director, Vascular Biology and Therapeutics (VBT) Program, Departments of Comparative Medicine and Pathology, Yale Center for Molecular and Systemic Metabolism (YMSM), Yale University School of Medicine
It seems to me a well-deserved Nobel Prize. The two laureates discovered small RNA molecules that post-transcriptionally regulate gene expression of the vast majority of genes. Ruvkun and Ambros identified these molecules by studying the development of the nematode C. elegans when they observed that a small RNA molecule, Lin-4, suppressed the expression of Lin-14 during the development process of this organism. Altered expression of these molecules is associated with numerous pathophysiological processes, including cancer, neurodegenerative and cardiometabolic diseases. The possibility exists to manipulate the expression of these molecules for the treatment of these diseases. On the other hand, the discovery of microRNAs is a very relevant finding, since these molecules control numerous basic cellular and physiological processes such as development, cell proliferation and cholesterol metabolism.